Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Kaps

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Cancers|February 13, 2025
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle FormulationsErsin Karatayli, Shifana C Sadiq, Jörn M Schattenberg, et al.
Cells|September 3, 2020
Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor TherapyMaximiliano L Cacicedo, Carolina Medina-Montano, Leonard Kaps, et al.
United European Gastroenterology Journal|July 24, 2020
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseLeonard Kaps, Christian Labenz, Peter R Galle, et al.
Cells|November 24, 2023
A New Synthetic Curcuminoid Displays Antitumor Activities in Metastasized MelanomaLeonard Kaps, Adrian Klefenz, Henry Traenckner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 26, 2011
DNA-polymer micelles as nanoparticles with recognition abilityRenée Mayap Talom, Gad Fuks, Leonard Kaps, et al.
Journal of Inorganic Biochemistry|November 25, 2011
Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activitiesLeonard Kaps, Bernhard Biersack, Helge Müller-Bunz, et al.
Chemmedchem|March 21, 2014
Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potentialJulienne K Muenzner, Bernhard Biersack, Hussein Kalie, et al.
Biomacromolecules|January 21, 2022
Fluorescence Correlation Spectroscopy Monitors the Fate of Degradable Nanocarriers in the Blood StreamSascha Schmitt, Anne Huppertsberg, Adrian Klefenz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2023
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosisEva Maria Schleicher, Leonard Kaps, Jörn M Schattenberg, et al.
Hepatology Communications|December 2, 2024
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese miceNadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Cancers|February 13, 2025
Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle FormulationsErsin Karatayli, Shifana C Sadiq, Jörn M Schattenberg, et al.
Cells|September 3, 2020
Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor TherapyMaximiliano L Cacicedo, Carolina Medina-Montano, Leonard Kaps, et al.
United European Gastroenterology Journal|July 24, 2020
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseLeonard Kaps, Christian Labenz, Peter R Galle, et al.
Cells|November 24, 2023
A New Synthetic Curcuminoid Displays Antitumor Activities in Metastasized MelanomaLeonard Kaps, Adrian Klefenz, Henry Traenckner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 26, 2011
DNA-polymer micelles as nanoparticles with recognition abilityRenée Mayap Talom, Gad Fuks, Leonard Kaps, et al.
Journal of Inorganic Biochemistry|November 25, 2011
Gold(I)-NHC complexes of antitumoral diarylimidazoles: structures, cellular uptake routes and anticancer activitiesLeonard Kaps, Bernhard Biersack, Helge Müller-Bunz, et al.
Chemmedchem|March 21, 2014
Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 address different targets and show antimetastatic potentialJulienne K Muenzner, Bernhard Biersack, Hussein Kalie, et al.
Biomacromolecules|January 21, 2022
Fluorescence Correlation Spectroscopy Monitors the Fate of Degradable Nanocarriers in the Blood StreamSascha Schmitt, Anne Huppertsberg, Adrian Klefenz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 17, 2023
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosisEva Maria Schleicher, Leonard Kaps, Jörn M Schattenberg, et al.
Hepatology Communications|December 2, 2024
Blocking interleukin-1 receptor type 1 (IL-1R1) signaling in hepatocytes slows down diethylnitrosamine-induced liver tumor growth in obese miceNadine Gehrke, Lea J Hofmann, Beate K Straub, et al.
Pageof 7